- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 7, 2026 | 57.4M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 57.29M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 57.27M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 57M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 56.75M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $45K |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $60.49K |
| Capex | Q3 2026 · Mar 31, 2026 | $324.23K |
| Capex | Q3 2026 · Mar 31, 2025 | $140.96K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$3.19M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$12.07M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $18.03M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $24.35M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $23.52M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | −$16.2M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$7.66M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $604.69K |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $14.79M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $24.23M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $34.46M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $54.85M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $72.54M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $92.12M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $101.61M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $55.74M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $72.91M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $75.91M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $102.22M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.17 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.34 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.19 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.43 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.17 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.34 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.19 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.43 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $4.82M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $14M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $7.6M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $23.28M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$9.52M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$19.38M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$10.86M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$24.45M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$9.48M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$19.05M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$10.59M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$23.21M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $1.99M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $10.61M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $4.78M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $20.17M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $16.69M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $58.71M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $21.41M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $87.18M |
| Revenue | Q3 2026 · Mar 31, 2026 | $18.69M |
| Revenue | Q3 2026 · Mar 31, 2026 | $69.32M |
| Revenue | Q3 2026 · Mar 31, 2025 | $26.19M |
| Revenue | Q3 2026 · Mar 31, 2025 | $107.36M |